{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Nigella sativa L.", "SARS-CoV-2", "black seed", "clinical trial", "invention", "patent"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35566101", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "19"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "25"}], "Language": ["eng"], "ELocationID": ["2750", "10.3390/molecules27092750"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "25"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "<i>Nigella sativa</i> L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.", "Abstract": {"AbstractText": ["COVID-19 has had an impact on human quality of life and economics. Scientists have been identifying remedies for its prevention and treatment from all possible sources, including plants. <i>Nigella sativa</i> L. (NS) is an important medicinal plant of Islamic value. This review highlights the anti-COVID-19 potential, clinical trials, inventions, and patent literature related to NS and its major chemical constituents, like thymoquinone. The literature was collected from different databases, including Pubmed, Espacenet, and Patentscope. The literature supports the efficacy of NS, NS oil (NSO), and its chemical constituents against COVID-19. The clinical data imply that NS and NSO can prevent and treat COVID-19 patients with a faster recovery rate. Several inventions comprising NS and NSO have been claimed in patent applications to prevent/treat COVID-19. The patent literature cites NS as an immunomodulator, antioxidant, anti-inflammatory, a source of anti-SARS-CoV-2 compounds, and a plant having protective effects on the lungs. The available facts indicate that NS, NSO, and its various compositions have all the attributes to be used as a promising remedy to prevent, manage, and treat COVID-19 among high-risk people as well as for the therapy of COVID-19 patients of all age groups as a monotherapy or a combination therapy. Many compositions of NS in combination with countless medicinal herbs and medicines are still unexplored. Accordingly, the authors foresee a bright scope in developing NS-based anti-COVID-19 composition for clinical use in the future."]}, "AuthorList": [{"Identifier": ["0000-0002-6064-1040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia."}], "LastName": "Imran", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": ["0000-0002-0729-3403"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, National University of Science and Technology, Muscat 130, Oman."}], "LastName": "Khan", "ForeName": "Shah Alam", "Initials": "SA"}, {"Identifier": ["0000-0001-6186-461X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia."}], "LastName": "Abida"}, {"Identifier": ["0000-0001-6687-0461"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Care, Rafha Central Hospital, Rafha 91911, Saudi Arabia."}], "LastName": "Alshammari", "ForeName": "Mohammed Kanan", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Care, King Khalid Hospital in Majmaah, Riyadh 76312, Saudi Arabia."}], "LastName": "Alkhaldi", "ForeName": "Saif M", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Community Pharmacist, Al-Dawaa Pharmacies, Hafer Albatin 39911, Saudi Arabia."}], "LastName": "Alshammari", "ForeName": "Fayez Nafea", "Initials": "FN"}, {"Identifier": ["0000-0002-3585-0828"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Kamal", "ForeName": "Mehnaz", "Initials": "M"}, {"Identifier": ["0000-0003-0322-2509"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India."}], "LastName": "Alam", "ForeName": "Ozair", "Initials": "O"}, {"Identifier": ["0000-0003-1533-9667"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia."}], "LastName": "Asdaq", "ForeName": "Syed Mohammed Basheeruddin", "Initials": "SMB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar 91431, Saudi Arabia."}], "LastName": "Alzahrani", "ForeName": "A Khuzaim", "Initials": "AK"}, {"Identifier": ["0000-0002-9551-6434"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Department, Sulaiman Al-Habib Medical Group, Riyadh 11643, Saudi Arabia."}], "LastName": "Jomah", "ForeName": "Shahamah", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inventions"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nigella sativa"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Worldometer on COVID-19 Cases.  [(accessed on 1 April 2022)].  Available online:  https://www.worldometers.info/coronavirus/"}, {"Citation": "Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141\u2013154. doi: 10.1038/s41579-020-00459-7.", "ArticleIdList": ["10.1038/s41579-020-00459-7", "PMC7537588", "33024307"]}, {"Citation": "Emergency Use Authorization.  [(accessed on 31 March 2022)]; Available online:  https://www.fda.gov.ph/list-of-fda-issued-emergency-use-authorization/"}, {"Citation": "Alshrari A.S., Hudu S.A., Imran M., Asdaq S.M.B., Ali A.M., Rabbani S.I. Innovations and development of COVID-19 vaccines: A patent review. J. Infect. Public Health. 2022;15:123\u2013131. doi: 10.1016/j.jiph.2021.10.021.", "ArticleIdList": ["10.1016/j.jiph.2021.10.021", "PMC8539827", "34742639"]}, {"Citation": "Asdaq S.M.B., Rajan A., Damodaran A., Kamath S.R., Nair K.S., Zachariah S.M., Sahu R.K., Fattepur S., Sreeharsha N., Nair A., et al. Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention. Antibiotics. 2021;10:1308. doi: 10.3390/antibiotics10111308.", "ArticleIdList": ["10.3390/antibiotics10111308", "PMC8615244", "34827246"]}, {"Citation": "Asdaq S.M.B., Rabbani S.I., Alkahtani M., Aldohyan M.M., Alabdulsalam A.M., Alshammari M.S., Alajlan S.A., Binrokan A., Mohzari Y., Alrashed A., et al. A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19. Int. J. Mol. Sci. 2021;22:11953. doi: 10.3390/ijms222111953.", "ArticleIdList": ["10.3390/ijms222111953", "PMC8584575", "34769383"]}, {"Citation": "Arora M.K., Grover P., Asdaq S.M.B., Mehta L., Tomar R., Imran M., Pathak A., Jangra A., Sahoo J., Alamri A.S., et al. Potential role of nicotinamide analogues against SARS-COV-2 target proteins. Saudi J. Biol. Sci. 2021;28:7567\u20137574. doi: 10.1016/j.sjbs.2021.09.072.", "ArticleIdList": ["10.1016/j.sjbs.2021.09.072", "PMC8482651", "34608370"]}, {"Citation": "Asdaq S.M.B., Ikbal A.M.A., Sahu R.K., Bhattacharjee B., Paul T., Deka B., Fattepur S., Widyowati R., Vijaya J., Al Mohaini M., et al. Nanotechnology integration for SARS-CoV-2 diagnosis and treatment: An approach to preventing pandemic. Nanomaterials. 2021;11:1841. doi: 10.3390/nano11071841.", "ArticleIdList": ["10.3390/nano11071841", "PMC8308419", "34361227"]}, {"Citation": "Asdaq S.M.B., Alshrari A.S., Imran M., Sreeharsha N., Sultana R. Knowledge, attitude and practices of healthcare professionals of Riyadh, Saudi Arabia towards COVID-19: A cross-sectional study. Saudi J. Biol. Sci. 2021;28:5275\u20135282.", "ArticleIdList": ["PMC8142078", "34054326"]}, {"Citation": "Asdaq S.M.B., Rabbani S.I., Imran M., Alanazi A.A., Alnusir G.Y., Al-Shammari A.A., Alsubaie F.H., Alsalman A.J. A review on potential antimutagenic plants of Saudi Arabia. Appl. Sci. 2021;11:8494. doi: 10.3390/app11188494.", "ArticleIdList": ["10.3390/app11188494"]}, {"Citation": "Villena-Tejada M., Vera-Ferchau I., Cardona-Rivero A., Zamalloa-Cornejo R., Quispe-Florez M., Frisancho-Trive\u00f1o Z., Abarca-Mel\u00e9ndez R.C., Alvarez-Sucari S.G., Mejia C.R., Ya\u00f1ez J.A. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey. PLoS ONE. 2021;16:e0257165. doi: 10.1371/journal.pone.0257165.", "ArticleIdList": ["10.1371/journal.pone.0257165", "PMC8457479", "34550994"]}, {"Citation": "Hariyanto T.I., Intan D., Hananto J.E., Harapan H., Kurniawan A. Vitamin D supplementation and COVID-19 outcomes: A 614 systematic review, meta-analysis and meta-regression. Rev. Med. Virol. 2021;32:e2269. doi: 10.1002/rmv.2269.", "ArticleIdList": ["10.1002/rmv.2269", "PMC8420102", "34331330"]}, {"Citation": "Ahmad A., Husain A., Mujeeb M., Khan S.A., Najmi A.K., Siddique N.A., Damanhouri Z.A., Anwar F. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac. J. Trop. Biomed. 2013;3:337\u2013352. doi: 10.1016/S2221-1691(13)60075-1.", "ArticleIdList": ["10.1016/S2221-1691(13)60075-1", "PMC3642442", "23646296"]}, {"Citation": "Ahmad I., Tripathi J., Manik S., Umar L., Rabia J. Preliminary phytochemical studies of the miracle herb of the century, Nigella sativa L. (Black seed) Indo Am. J. Pharm. Res. 2013;3:3000\u20133007."}, {"Citation": "Yimer E.M., Tuem K.B., Karim A., Ur-Rehman N., Anwar F. Nigella sativa L. (Black Cumin): A promising natural remedy for wide range of illnesses. Evid. Based Complement. Altern. Med. 2019;2019:1528635. doi: 10.1155/2019/1528635.", "ArticleIdList": ["10.1155/2019/1528635", "PMC6535880", "31214267"]}, {"Citation": "Naz H. Nigella sativa: The miraculous herb. Pak. J. Biochem. Mol. Biol. 2011;44:44\u201348."}, {"Citation": "Ijaz H., Tulain U.R., Qureshi J., Danish Z., Musayab S., Akhtar M.F., Saleem A., Khan K.A., Zaman M., Waheed I., et al. Nigella sativa (Prophetic Medicine): A review. Pak. J. Pharm. Sci. 2017;30:229\u2013234.", "ArticleIdList": ["28603137"]}, {"Citation": "Ismail M.Y., Yaheya M. Therapeutic role of prophetic medicine Habbat El Baraka (Nigella sativa L.)\u2014A review. World Appl. Sci. J. 2009;7:1203\u20131208."}, {"Citation": "Yarnell E., Abascal K. Nigella sativa: Holy herb of the middle East. Altern. Complement. Ther. 2011;17:99\u2013105. doi: 10.1089/act.2011.17203.", "ArticleIdList": ["10.1089/act.2011.17203"]}, {"Citation": "El-Tahir K.E., Bakeet D.M. The black seed Nigella sativa Linnaeus-A mine for multi cures: A plea for urgent clinical evaluation of its volatile oil. J. Taibah. Univ. Med. Sci. 2006;1:1\u201319."}, {"Citation": "Sudhir S.P., Deshmukh V.O., Verma H.N. Nigella sativa seed, a novel beauty care ingredient: A review. Int. J. Pharm. Sci. Res. 2016;7:3185."}, {"Citation": "Dajani E.Z., Shahwan T.G., Dajani N.E. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): A complementary drug with historical and clinical significance. J. Physiol. Pharmacol. 2016;67:801\u2013817.", "ArticleIdList": ["28195061"]}, {"Citation": "Areefa A., Mohd A., Shah C.S. A review on Nigella sativa (Kalonji) seeds: A universal healer. Cellmed. 2020;10:11.1\u201311.14."}, {"Citation": "Begum S., Mannan A. A review on Nigella sativa: A Marvel herb. J. Drug Deliv. Therap. 2020;10:213\u2013219. doi: 10.22270/jddt.v10i2.3913.", "ArticleIdList": ["10.22270/jddt.v10i2.3913"]}, {"Citation": "Thakur S., Kaurav H., Chaudhary G. Nigella sativa (Kalonji): A black seed of miracle. Int. J. Res. Rev. 2021;8:342\u2013357. doi: 10.52403/ijrr.20210441.", "ArticleIdList": ["10.52403/ijrr.20210441"]}, {"Citation": "Momin M., Momin S., Kurhade S., Butte K. Nigella sativa: Blessed seed. Int. J. Res. Phytochem. Pharmacol. 2013;3:78\u201384."}, {"Citation": "Ara I., Maqbool M., Fekadu G., Hajam T.A., Dar M.A. Pharmaceutical significance of Nigella Sativa L., a Wonder herb. J. Appl. Pharm. Sci. Res. 2020;3:4\u201313. doi: 10.31069/japsr.v3i4.2.", "ArticleIdList": ["10.31069/japsr.v3i4.2"]}, {"Citation": "Salehi B., Quispe C., Imran M., Ul-Haq I., \u017divkovi\u0107 J., Abu-Reidah I.M., Sen S., Taheri Y., Acharya K., Azadi H., et al. Nigella plants-Traditional uses, bioactive phytoconstituents, preclinical and clinical studies. Front. Pharmacol. 2021;12:625386. doi: 10.3389/fphar.2021.625386.", "ArticleIdList": ["10.3389/fphar.2021.625386", "PMC8107825", "33981219"]}, {"Citation": "Hannan M.A., Rahman M.A., Sohag A.A.M., Uddin M.J., Dash R., Sikder M.H., Rahman M.S., Timalsina B., Munni Y.A., Sarker P.P., et al. Black cumin (Nigella sativa L.): A comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients. 2021;13:1784. doi: 10.3390/nu13061784.", "ArticleIdList": ["10.3390/nu13061784", "PMC8225153", "34073784"]}, {"Citation": "Mazaheri Y., Torbati M., Damirchi S.A., Geoffrey P., Savage G.P. A comprehensive review of the physicochemical, quality and nutritional properties of Nigella sativa oil. Food Rev. Int. 2019;35:342\u2013362. doi: 10.1080/87559129.2018.1563793.", "ArticleIdList": ["10.1080/87559129.2018.1563793"]}, {"Citation": "Farooq J., Sultana R., Taj T., Asdaq S.M.B., Alsalman A.J., Mohaini M.A., Al Hawaj M.A., Kamal M., Alghamdi S., Imran M., et al. Insights into the protective effects of thymoquinone against toxicities induced by chemotherapeutic agents. Molecules. 2021;27:226. doi: 10.3390/molecules27010226.", "ArticleIdList": ["10.3390/molecules27010226", "PMC8746502", "35011457"]}, {"Citation": "Khan M.A., Afzal M. Chemical composition of Nigella sativa Linn: Part 2 Recent advances. Inflammopharmacology. 2016;24:67\u201379. doi: 10.1007/s10787-016-0262-7.", "ArticleIdList": ["10.1007/s10787-016-0262-7", "PMC4883276", "27068721"]}, {"Citation": "Khan S., Ali M., Albratty M.M., Najmi A.Y., Azeem U., Khan S.A., Rather M.A. Black Seeds (Nigella sativa) Elsevier; Amsterdam, The Netherlands: 2022. Nigella sativa: From chemistry to medicine; pp. 29\u201362."}, {"Citation": "Gholamnezhad Z., Havakhah S., Boskabady M.H. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. J. Ethnopharmacol. 2016;190:372\u2013386. doi: 10.1016/j.jep.2016.06.061.", "ArticleIdList": ["10.1016/j.jep.2016.06.061", "27364039"]}, {"Citation": "Khan M.A., Tania M., Fu S., Fu J. Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget. 2017;8:51907\u201351919. doi: 10.18632/oncotarget.17206.", "ArticleIdList": ["10.18632/oncotarget.17206", "PMC5584300", "28881699"]}, {"Citation": "Samarghandian S., Farkhondeh T., Samini F. A review on possible therapeutic effect of Nigella sativa and thymoquinone in neurodegenerative diseases. CNS Neurol. Disord. Drug Targets. 2018;17:412\u2013420. doi: 10.2174/1871527317666180702101455.", "ArticleIdList": ["10.2174/1871527317666180702101455", "29962349"]}, {"Citation": "Balbaa M., El-Zeftawy M., Abdulmalek S.A., Shahin Y.R. Black Cumin (Nigella sativa) Seeds: Chemistry, Technology, Functionality, and Application. Springer; Cham, Switzerland: 2021. Health-promoting activities of Nigella sativa fixed oil; pp. 361\u2013379."}, {"Citation": "Gheita T.A., Kenawy S.A. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: A placebo controlled study. Phytother. Res. 2012;26:1246\u20131248. doi: 10.1002/ptr.3679.", "ArticleIdList": ["10.1002/ptr.3679", "22162258"]}, {"Citation": "Goyal S.N., Prajapati C.P., Gore P.R., Patil C.R., Mahajan U.B., Sharma C., Talla S.P., Ojha S.K. Therapeutic potential and pharmaceutical development of thymoquinone: A multitargeted molecule of natural origin. Front. Pharmacol. 2017;8:656. doi: 10.3389/fphar.2017.00656.", "ArticleIdList": ["10.3389/fphar.2017.00656", "PMC5613109", "28983249"]}, {"Citation": "Kalamegam G., Alfakeeh S.M., Bahmaid A.O., AlHuwait E.A., Gari M.A., Abbas M.M., Ahmed F., Abu-Elmagd M., Pushparaj P.N. In vitro Evaluation of the anti-inflammatory effects of thymoquinone in osteoarthritis and in silico analysis of inter-related pathways in age-related degenerative diseases. Front. Cell Dev. Biol. 2020;8:646. doi: 10.3389/fcell.2020.00646.", "ArticleIdList": ["10.3389/fcell.2020.00646", "PMC7391788", "32793594"]}, {"Citation": "Boskabady M., Khazdair M.R., Bargi R., Saadat S., Memarzia A., Roshan N.M., Hosseini M., Askari V.R., Boskabady M.H. Thymoquinone ameliorates lung inflammation and pathological changes observed in lipopolysaccharide-induced lung injury. Evid. Based Complement. Altern. Med. 2021;2021:6681729. doi: 10.1155/2021/6681729.", "ArticleIdList": ["10.1155/2021/6681729", "PMC8024078", "33859710"]}, {"Citation": "Shaterzadeh-Yazdi H., Noorbakhsh M.F., Hayati F., Samarghandian S., Farkhondeh T. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc. Hematol. Disord. Drug Targets. 2018;18:52\u201360. doi: 10.2174/1871529X18666180212114816.", "ArticleIdList": ["10.2174/1871529X18666180212114816", "29437018"]}, {"Citation": "Mahmoud Y.K., Abdelrazek H.M.A. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy. Biomed. Pharmacother. 2019;115:108783. doi: 10.1016/j.biopha.2019.108783.", "ArticleIdList": ["10.1016/j.biopha.2019.108783", "31060003"]}, {"Citation": "AbuKhader M.M., Khan S.A. Thymoquinone and nanoparticles: A promising approach for the clinical trials. J. Bionanosci. 2017;11:258\u2013265. doi: 10.1166/jbns.2017.1447.", "ArticleIdList": ["10.1166/jbns.2017.1447"]}, {"Citation": "Staniek K., Gille L. Is thymoquinone an antioxidant? BMC Pharmacol. 2010;10:A9. doi: 10.1186/1471-2210-10-S1-A9.", "ArticleIdList": ["10.1186/1471-2210-10-S1-A9"]}, {"Citation": "Wienk\u00f6tter N., H\u00f6pner D., Sch\u00fctte U., Bauer K., Begrow F., El-Dakhakhny M., Verspohl E.J. The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. Planta Med. 2008;74:105\u2013108. doi: 10.1055/s-2008-1034280.", "ArticleIdList": ["10.1055/s-2008-1034280", "18219598"]}, {"Citation": "Adamska A., Stefanowicz-Hajduk J., Ochocka J.R. Alpha-Hederin, the active saponin of Nigella sativa, as an anticancer agent inducing apoptosis in the SKOV-3 cell line. Molecules. 2019;24:2958. doi: 10.3390/molecules24162958.", "ArticleIdList": ["10.3390/molecules24162958", "PMC6719954", "31443189"]}, {"Citation": "Gepdiremen A., Mshvildadze V., S\u00fcleyman H., Elias R. Acute anti-inflammatory activity of four saponins isolated from ivy: Alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine. 2005;12:440\u2013444. doi: 10.1016/j.phymed.2004.04.005.", "ArticleIdList": ["10.1016/j.phymed.2004.04.005", "16008120"]}, {"Citation": "Saadat S., Mohammadi M., Fallahi M., Keyhanmanesh R., Aslani M.R. The protective effect of \u03b1-hederin, the active constituent of Nigella sativa, on tracheal responsiveness and lung inflammation in ovalbumin-sensitized guinea pigs. J. Physiol. Sci. 2015;65:285\u2013292. doi: 10.1007/s12576-015-0367-6.", "ArticleIdList": ["10.1007/s12576-015-0367-6", "25752254"]}, {"Citation": "Khazdair M.R., Ghafari S., Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm. Biol. 2021;59:696\u2013703. doi: 10.1080/13880209.2021.1931353.", "ArticleIdList": ["10.1080/13880209.2021.1931353", "PMC8204995", "34110959"]}, {"Citation": "Khan S.A., Al-Balushi K. Combating COVID-19: The role of drug repurposing and medicinal plants. J. Infect. Public Health. 2021;14:495\u2013503. doi: 10.1016/j.jiph.2020.10.012.", "ArticleIdList": ["10.1016/j.jiph.2020.10.012", "PMC7590838", "33743371"]}, {"Citation": "Koshak A.E., Koshak E.A., Mobeireek A.F., Badawi M.A., Wali S.O., Malibary H.M., Atwah A.F., Alhamdan M.M., Almalki R.A., Madani T.A. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement. Ther. Med. 2021;61:102769. doi: 10.1016/j.ctim.2021.102769.", "ArticleIdList": ["10.1016/j.ctim.2021.102769", "PMC8364675", "34407441"]}, {"Citation": "Badary O.A., Hamza M.S., Tikamdas R. Thymoquinone: A Promising natural compound with potential benefits for COVID-19 prevention and cure. Drug Des. Dev. Ther. 2021;15:1819\u20131833. doi: 10.2147/DDDT.S308863.", "ArticleIdList": ["10.2147/DDDT.S308863", "PMC8106451", "33976534"]}, {"Citation": "Islam M.N., Hossain K.S., Sarker P.P., Ferdous J., Hannan M.A., Rahman M.M., Chu D.T., Uddin M.J. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytother. Res. 2021;35:1329\u20131344. doi: 10.1002/ptr.6895.", "ArticleIdList": ["10.1002/ptr.6895", "PMC7675410", "33047412"]}, {"Citation": "Banerjee A., Kanwar M., Mohapatra P.K.D., Saso L., Nicoletti M., Maiti S. Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription and FAS-TNF death signal via TNFR 1/2 blocking. Nat. Prod. Res. 2021:1\u20136. doi: 10.1080/14786419.2021.2018430.", "ArticleIdList": ["10.1080/14786419.2021.2018430", "34937447"]}, {"Citation": "Duru C.E., Duru I.A., Adegboyega A.E. In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets. Bull. Natl. Res. Cent. 2021;45:57. doi: 10.1186/s42269-021-00517-x.", "ArticleIdList": ["10.1186/s42269-021-00517-x", "PMC7952832", "33727782"]}, {"Citation": "Ahmad S., Abbasi H.W., Shahid S., Gul S., Abbasi S.W. Molecular docking, simulation and MM-PBSA studies of Nigella sativa compounds: A computational quest to identify potential natural antiviral for COVID-19 treatment. J. Biomol. Struct. Dyn. 2021;39:4225\u20134233. doi: 10.1080/07391102.2020.1775129.", "ArticleIdList": ["10.1080/07391102.2020.1775129", "PMC7298883", "32462996"]}, {"Citation": "Mir S.A., Firoz A., Alaidarous M., Alshehri B., Bin Dukhyil A.A., Banawas S., Alsagaby S.A., Alturaiki W., Bhat G.A., Kashoo F., et al. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach. Saudi J. Biol. Sci. 2022;29:394\u2013401. doi: 10.1016/j.sjbs.2021.09.002.", "ArticleIdList": ["10.1016/j.sjbs.2021.09.002", "PMC8426002", "34518755"]}, {"Citation": "Rizvi S.M.D., Hussain T., Moin A., Dixit S.R., Mandal S.P., Adnan M., Jamal Q.M.S., Sharma D.C., Alanazi A.S., Unissa R. Identifying the most potent dual-targeting compound(s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from Nigella sativa: Virtual screening via physicochemical properties, docking and dynamic simulation analysis. Processes. 2021;9:1814. doi: 10.3390/pr9101814.", "ArticleIdList": ["10.3390/pr9101814"]}, {"Citation": "Baig A., Srinivasan H. SARS-CoV-2 Inhibitors from Nigella sativa. Appl. Biochem. Biotechnol. 2022;194:1051\u20131092. doi: 10.1007/s12010-021-03790-8.", "ArticleIdList": ["10.1007/s12010-021-03790-8", "PMC8803537", "35102539"]}, {"Citation": "Maiti S., Banerjee A., Nazmeen A., Kanwar M., Das S. Active-site Molecular docking of Nigellidine with nucleocapsid- NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats. J. Drug Target. 2022;30:511\u2013521. doi: 10.1080/1061186X.2020.1817040.", "ArticleIdList": ["10.1080/1061186X.2020.1817040", "32875925"]}, {"Citation": "Khan S.L., Siddiqui F.A., Jain S.P., Sonwane G.M. Discovery of potential inhibitors of SARS-CoV-2 (COVID-19) main protease (Mpro) from Nigella sativa (Black seed) by molecular docking study. Coronaviruses. 2021;2:384\u2013402. doi: 10.2174/2666796701999200921094103.", "ArticleIdList": ["10.2174/2666796701999200921094103"]}, {"Citation": "Mani R.J., Sehgal N., Dogra N., Saxena S., Katare D.P. Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: In-silico study. J. Biomol. Struct. Dyn. 2022;40:2417\u20132429. doi: 10.1080/07391102.2020.1839560.", "ArticleIdList": ["10.1080/07391102.2020.1839560", "PMC7605643", "33111624"]}, {"Citation": "Pandey P., Khan F., Mazumder A., Rana A.K., Srivastava Y. Inhibitory potential of dietary phytocompounds of Nigella sativa against key targets of novel coronavirus (COVID-19) Indian J. Pharm. Educ. Res. 2021;55:190\u2013197. doi: 10.5530/ijper.55.1.21.", "ArticleIdList": ["10.5530/ijper.55.1.21"]}, {"Citation": "Esharkawy E.R., Almalki F., Hadda T.B. In vitro potential antiviral SARS-CoV-19- activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa. Bioorg. Chem. 2022;102:105587. doi: 10.1016/j.bioorg.2021.105587.", "ArticleIdList": ["10.1016/j.bioorg.2021.105587", "PMC8719923", "35026560"]}, {"Citation": "Xu H., Liu B., Xiao Z., Zhou M., Ge L., Jia F., Liu Y., Jin H., Zhu X., Gao J., et al. Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect. Dis. Ther. 2021;10:483\u2013494. doi: 10.1007/s40121-021-00400-2.", "ArticleIdList": ["10.1007/s40121-021-00400-2", "PMC7853165", "33532909"]}, {"Citation": "U.S. National Library of Medicine.  [(accessed on 1 April 2022)]; Available online:  https://clinicaltrials.gov/ct2/home."}, {"Citation": "Imran M., Alshrari S.A., Thabet H.K., Abida Bakht A.M. Synthetic molecules as DprE1 inhibitors: A patent review. Expert Opin. Ther. Patents. 2021;31:759\u2013772. doi: 10.1080/13543776.2021.1902990.", "ArticleIdList": ["10.1080/13543776.2021.1902990", "33709862"]}, {"Citation": "Imran M., Alshrari S.A., Tauseef M., Khan S.A., Hudu S.A., Abid Mucormycosis medications: A patent review. Expert Opin. Ther. Patents. 2021;31:1059\u20131074. doi: 10.1080/13543776.2021.1939308.", "ArticleIdList": ["10.1080/13543776.2021.1939308", "34082658"]}, {"Citation": "Imran M., Asdaq S.M.B., Khan S.A., Unnikrishnan M.D., Alamri A.S., Alsanie W.F., Alhomrani M., Mohzari Y., Alrashed A., AlMotairi M., et al. Innovations and patent trends in the development of USFDA approved protein kinase inhibitors in the last two decades. Pharmaceuticals. 2021;14:710. doi: 10.3390/ph14080710.", "ArticleIdList": ["10.3390/ph14080710", "PMC8400070", "34451807"]}, {"Citation": "Imran M., Khan S.A., Alshammari M.K., Alreshidi M.A., Alreshidi A.A., Alghonaim R.S., Alanazi F.A., Alshehri S., Ghoneim M.M., Shakeel F. Discovery, development, inventions, and patent trends on Mobocertinib succinate: The first-in-class oral treatment for NSCLC with EGFR Exon 20 insertions. Biomedicines. 2021;9:1938. doi: 10.3390/biomedicines9121938.", "ArticleIdList": ["10.3390/biomedicines9121938", "PMC8698942", "34944754"]}, {"Citation": "Ichim T.E., Dixon T.G., Veltmeyer J. Nutraceuticals for Suppressing Indolamine 2,3 Deoxygenase. U.S. Patent Number US11229674B1. 2022 January 25;"}, {"Citation": "Ichim T.E., Dixon T.G. Nutraceuticals for the Prevention, Inhibition, and Treatment of SARS-Cov-2 and Associated COVID-19. U.S. Patent Application Publication Number US20210338763A1. 2021 November 4;"}, {"Citation": "Haddadi M., Taghdisi H.P.M. Herbal Medicine for the Treatment of COVID-19. PCT International Patent Application Publication Number WO2022009236A1. 2022 January 13;"}, {"Citation": "Al Jasim N.A.N., Ahmed N.Z. Immunomodulatory Composition to Treat and/or Prevent COVID-19 Illness. U.S. Patent Application Publication Number US20220000958A1. 2022 January 6;"}, {"Citation": "Omar A. Herbal Anti-Viral Drug Containing Black Seed Oil for Treating Coronavirus Disease (COVID-19) Turkish Patent Application Publication Number TR2020004046A2. 2020 April 21;"}, {"Citation": "Muhammad T. Compositions and Prevention and Intervention Methods for COVID-19 with Divine Ayats\u2019 Fitra30 COVID-19 Protocol. PCT International Patent Application Publication Number WO202120. 2021 October 14;"}, {"Citation": "Ichim T.E., Veltmeyer J., Dixon T.G. Additive and/or Synergistic Combinations of Metformin with Nutraceuticals for the Prevention, Inhibition and Treatment of Sars-Cov-2 and Associated COVID-19. U.S. Patent Application Publication Number US2022023237A1. 2022 January 27;"}, {"Citation": "Ichim T.E., Dixon T.G., Veltmeyer J. Neuroprotection and Neuroregeneration by Pterostilbene and Compositions Thereof. U.S. Patent Application Publication Number US2022031793A1. 2022 February 3;"}, {"Citation": "Ichim T.E., Ramos F., Veltmeyer J., Dixon T.G. Prevention of Neuroinflammation Associated Memory Loss Using Nutraceutical Compositions. U.S. Patent Application Publication Number US2022040248A1. 2022 February 10;"}, {"Citation": "Alkalay R. Compositions and Methods for Treating and Preventing a Coronavirus Infection. PCT International Patent Application Publication Number WO2021186453A1. 2021 September 23;"}, {"Citation": "Alkalay R. Compositions and Methods for Treating and Preventing Non-Malignant Respiratory Disease. PCT International Patent Application Publication Number WO2021186454A1. 2021 September 23;"}, {"Citation": "Alkalay R. Compositions and Methods for Treating or Preventing Inflammatory Diseases Including Diabetes Mellitus 10 Type I and Type II and Thyroid Diseases. PCT International Patent Application Publication Number WO2021186455A1. 2021 September 23;"}, {"Citation": "Alkalay R. Compositions and Methods for Treating Solid and Soft Tumors and Proliferative Diseases. PCT International Patent Application Publication Number WO2021186456A1. 2021 September 23;"}, {"Citation": "Popov T., Josling P.D. Compositions and Applications Thereof. PCT International Patent Application Publication Number WO2021160982A1. 2021 August 19;"}, {"Citation": "Hoag G.E., Salerno J. Method for Treating Viral and Bacterial Infection through Inhalation Therapy. PCT International Patent Application Publication Number WO2021216749A1. 2021 October 28;"}, {"Citation": "Mehmood A., Khan S., Khan S., Ahmed S., Ali A., Xue M., Ali L., Hamza M., Munir A., Ur Rehman S., et al. In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus. Saudi J. Biol. Sci. 2021;28:3137\u20133151. doi: 10.1016/j.sjbs.2021.02.058.", "ArticleIdList": ["10.1016/j.sjbs.2021.02.058", "PMC7899931", "33642896"]}, {"Citation": "Holgersen E.M., Gandhi S., Zhou Y., Kim J., Vaz B., Bogojeski J., Bugno M., Shalev Z., Cheung-Ong K., Gon\u00e7alves J., et al. Transcriptome-Wide off-target effects of steric-blocking oligonucleotides. Nucleic Acid Ther. 2021;31:392\u2013403. doi: 10.1089/nat.2020.0921.", "ArticleIdList": ["10.1089/nat.2020.0921", "PMC8713556", "34388351"]}, {"Citation": "From the American Association of Neurological Surgeons (AANS) American Society of Neuroradiology (ASNR) Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Canadian Interventional Radiology Association (CIRA) Congress of Neurological Surgeons (CNS) European Society of Minimally Invasive Neurological Therapy (ESMINT) European Society of Neuroradiology (ESNR) European Stroke Organization (ESO) Society for Cardiovascular Angiography and Interventions (SCAI) Society of Interventional Radiology (SIR) et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int. J. Stroke. 2018;13:612\u2013632.", "ArticleIdList": ["29786478"]}, {"Citation": "Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108:17\u201341. doi: 10.1002/JLB.3COVR0520-272R.", "ArticleIdList": ["10.1002/JLB.3COVR0520-272R", "PMC7323250", "32534467"]}, {"Citation": "Karimi M., Zarei A., Soleymani S., Jamalimoghadamsiahkali S., Asadi A., Shati M., Jafari M., Rezadoost H., Kordafshar G., Naghizadeh A., et al. Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial. Phytother. Res. 2021;35:6295\u20136309. doi: 10.1002/ptr.7277.", "ArticleIdList": ["10.1002/ptr.7277", "PMC8661819", "34606123"]}, {"Citation": "Malik S., Singh A., Negi P., Kapoor V.K. Thymoquinone: A small molecule from nature with high therapeutic potential. Drug Discov. Today. 2021;26:2716\u20132725. doi: 10.1016/j.drudis.2021.07.013.", "ArticleIdList": ["10.1016/j.drudis.2021.07.013", "34303824"]}, {"Citation": "Kulyar M.F., Li R., Mehmood K., Waqas M., Li K., Li J. Potential influence of Nigella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic. Phytomedicine. 2021;85:153277. doi: 10.1016/j.phymed.2020.153277.", "ArticleIdList": ["10.1016/j.phymed.2020.153277", "PMC7347483", "32773257"]}, {"Citation": "Kadil Y., Mouhcine M., Filali H. In Silico Investigation of the SARS CoV2 protease with thymoquinone, the major constituent of Nigella Sativa. Curr. Drug Discov. Technol. 2021;18:570\u2013573. doi: 10.2174/1570163817666200712164406.", "ArticleIdList": ["10.2174/1570163817666200712164406", "32652915"]}, {"Citation": "Khan M.A., Younus H. Potential implications of black seed and its principal constituent thymoquinone in the treatment of COVID-19 patients. Curr. Pharm. Biotechnol. 2021;22:1315\u20131324. doi: 10.2174/1389201021999201110205048.", "ArticleIdList": ["10.2174/1389201021999201110205048", "33176642"]}, {"Citation": "Awad E.M., Binder B.R. In vitro induction of endothelial cell fibrinolytic alterations by Nigella Sativa. Phytomedicine. 2005;12:194\u2013202. doi: 10.1016/j.phymed.2003.09.008.", "ArticleIdList": ["10.1016/j.phymed.2003.09.008", "15830841"]}, {"Citation": "Imran M., Alshrari A.S., Asdaq S.M.B., Abida Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review. J. Infect. Public Health. 2021;14:1075\u20131086. doi: 10.1016/j.jiph.2021.06.013.", "ArticleIdList": ["10.1016/j.jiph.2021.06.013", "PMC8236076", "34243049"]}, {"Citation": "Imran M., Kumar A.M., Asdaq S.M.B., Khan S.A., Alaqel S.I., Alshammari M.K., Alshehri M.M., Alshrari A.S., Mateq A.A., Al-Shammeri A.M., et al. Discovery, development, and patent trends on molnupiravir: A prospective oral treatment for COVID-19. Molecules. 2021;26:5795. doi: 10.3390/molecules26195795.", "ArticleIdList": ["10.3390/molecules26195795", "PMC8510125", "34641339"]}, {"Citation": "Ahmad M.F., Ahmad F.A., Ashraf S.A., Saad H.H., Wahab S., Khan M.I., Ali M., Mohan S., Hakeem K.R., Athar M.T. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J. Herb. Med. 2021;25:100404. doi: 10.1016/j.hermed.2020.100404.", "ArticleIdList": ["10.1016/j.hermed.2020.100404", "PMC7501064", "32983848"]}, {"Citation": "Tavakkoli A., Mahdian V., Razavi B.M., Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J. Pharmacopunct. 2017;20:179\u2013193.", "ArticleIdList": ["PMC5633670", "30087794"]}, {"Citation": "Webber P.M. A guide to drug discovery. Protecting your inventions: The patent system. Nat. Rev. Drug Discov. 2003;2:823\u2013830. doi: 10.1038/nrd1200.", "ArticleIdList": ["10.1038/nrd1200", "14526385"]}, {"Citation": "Jalal Z., Bakour M., Lyoussi B. Medicinal Plants and zinc: Impact on COVID-19 pandemic. Sci. World J. 2021;2021:9632034. doi: 10.1155/2021/9632034.", "ArticleIdList": ["10.1155/2021/9632034", "PMC8483924", "34602868"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "7"}, {"Year": "2022", "Month": "4", "Day": "13"}, {"Year": "2022", "Month": "4", "Day": "22"}, {"Year": "2022", "Month": "5", "Day": "14", "Hour": "1", "Minute": "23"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["35566101", "PMC9105261", "10.3390/molecules27092750", "molecules27092750"]}}], "PubmedBookArticle": []}